Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The Consumer Health of Merck Walks the Talk with its WE100 Movement

This image opens in the lightbox

News provided by

Merck

18 Jan, 2018, 09:00 GMT

Share this article

Share toX

Share this article

Share toX

DARMSTADT, Germany, January 18, 2018 /PRNewswire/ --

  • Consumer Health accelerates its WE100® movement by launching new partnership programme with pharmacists in the UK on enabling 100 years of healthy living 
  • Femibion® celebrates working mums with new "MumPlus" campaign 
  • Expansion of Vitamin D brand Vigantol® via the launch of Vigantolvit®
This image opens in the lightbox
Merck Consumer Health launches new program with pharmacists in the UK (PRNewsfoto/Merck)

Merck, a leading science and technology company, leverages its Consumer Health business' strong momentum, by launching several new programmes for the WE100 umbrella movement of the business and for two of its iconic brands. The We100 movement was established to bring the Consumer Health business purpose to life which aims to help prepare society for a new era of humans living 100 healthy years.

     (Photo: https://mma.prnewswire.com/media/628079/Merck_Role_of_Pharmacy.jpg )

New partnership program with UK pharmacists on healthy living 

After publishing a whitepaper (http://www.merckgroup.com/en/expertise/consumer-health/our-consumer-health-debate/white-paper.html ) in November 2017 shedding light on how to prepare younger generations to live 100 healthy years, the Consumer Health business of Merck continues to pursue its ambitious goal to help bridging the gap between "living longer" and "living longer and healthier". To this end, the business has renewed its partnership with pharmacists, by launching the new "Young for Old, Old for Young" dedicated training program in the UK.

The program focuses on supporting pharmacists to tackle specific challenges faced by ageing consumers, such as poor nutrition. According to the British Nutrition Foundation, a risk of malnutrition exists for as many as one in seven elderly people[1]. Thanks to the "Young for Old, Old for Young" dedicated training program, pharmacists will be able to improve their skills in recognizing the need for and providing consumers with the appropriate health and nutritional advice.

Uta Kemmerich-Keil, CEO and President of Merck Consumer Health, commented: "The philosophy behind WE100 is rooted in the belief that as people live longer lives, doing so as healthily as possible needs to be a top priority for all generations". In the UK, the WE100 program gained support and attention from policy makers, such as the member of parliament (MP) Eleanor Smith(Labour).

"MumPlus" campaign by Femibion celebrates working mothers 

A recent survey[2] by Femibion - a leading multivitamin for pregnancy and a strategic brand of the Consumer Health business - revealed that 62% percent of women believe having children will halt or delay career progression. Femibion therefore decided to call for a fundamental change of narrative in the workplace, to one where motherhood is rightly valued and something to be proud of. In the survey, 94% of women agreed with this objective, whilst admitting that reality did not always meet their expectations.

Through a series of creative videos, the brand wants to share the reassuring message that it should be a dualism of "motherhood AND career", not a decision between "either or". A MumPlus campaign LinkedIn page (https://de.linkedin.com/company/mumplus ) has been launched to inspire women to show support for the campaign and encourage employers to think differently about the working mothers around them. To further carry the campaign's message, a LinkedIn "badge" was developed which working mothers can add to their profile. By displaying the badge users can express that motherhood can add value to the workplace. Femibion continues to lead the way for digital transformation of the business, focusing the essential part of its marketing efforts on engaging with consumers online, for example through starting a discussion on LinkedIn, a crucial platform for working mums who are building their professional profile online.

Successful brand expansion keeps the spirit of Vigantol intact 

Vigantol, the No1 Vitamin D brand in Germany[3], successfully expanded its range with the launch of the food supplement Vigantolvit in Germany (2000 IU). This new product introduction contributed to a very strong double-digit growth of the brand in the market.

The recently launched Vigantolvit campaign is intended to showcase that a healthy and conscious lifestyle can help you prepare for an active future. The campaign is centred around a 60-year-old grandmother who continues to go surfing alongside her daughter and granddaughter. The campaign further illustrates the desire of Vigantolvit to help to bring generations together by enjoying an active lifestyle. based on the claim "Young with old. Old with Young.", the campaign is fully in line with Consumer Health´s purpose to help prepare society for a new era of humans living 100 healthy years.

About Merck's Consumer Health Business 

The Consumer Health business of Merck aims at helping to prepare society for a new era of humans living 100 healthy years. For this purpose, the business supports the so-called WE100® movement meant to activate projects and communication efforts accordingly. The leading "lovebrands" of Merck's Consumer Health business, such as Neurobion®, Bion®, Nasivin®, Seven Seas®, Dolo-Neurobion®, and Femibion® support this overarching purpose through consumer-inspired innovation. - The Consumer Health business is with over 3,800 employees globally active in over 40 markets. The portfolio comprises of brands with annual total sales of over $ 1 billion. Consumer Health is a business of the Healthcare business sector within the Merck Group with global headquarters in Darmstadt, Germany. For more information please go to http://www.merck-consumer-health.com or https://twitter.com/merck_ch

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.

About Merck 

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

_________________________________________

1. British Nutrition Foundation (2016). Older adults [online]. Available at: https://www.nutrition.org.uk/nutritionscience/life/older-adults.html?limit=1&start=5 [accessed 13 Feb. 2017].

2. Femibion survey conducted in 2017 in Germany

3. Insight Health Marktdaten, ehem. VIGANTOLETTEN®, Absatz MAT 08/2017

Contact: Lars Atorf, +49-6151-856-3114

     (Logo: http://photos.prnewswire.com/prnh/20160524/371574LOGO )

Modal title

Also from this source

Merck launches first-to-market, cyber-physical trust platform to tackle issues of product safety and counterfeiting

Merck launches first-to-market, cyber-physical trust platform to tackle issues of product safety and counterfeiting

Merck, a leading science and technology company, today launched a beta version of M-Trust™, a secure cyber-physical trust platform, created to help...

More Releases From This Source

Explore

Computer & Electronics

Computer & Electronics

Computer Software

Computer Software

Computer Software

Computer Software

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.